Table 2 Estimated treatment effects adjusted for regression-to-the-mean (in brackets: 95 % confidence intervals) (n = 5.421)
Treatment effect (RTM adjusted) | Standardised effecta (RTM adjusted) | p-value | |||
|---|---|---|---|---|---|
End of treatment | |||||
All patients | −18.6 | (−18.2 to −18.9) | −1.03 | (−1.01 to −1.05) | <.0001 |
Men | −19.3 | (−18.8 to −19.8) | −1.09 | (−1.06 to −1.12) | <.0001 |
Women | −17.8 | (−17.3 to −18.3) | −0.96 | (−0.94 to −0.99) | <.0001 |
Follow-up | |||||
All patients | −16.9 | (−29.0 to −4.8) | −0.93 | (−1.60 to −0.23) | 0.0342 |
Men | −17.3 | (−22.8 to −12.7) | −0.98 | (−1.29 to −0.66) | 0.0056 |
Women | −16.5 | (−22.7 to −10.4) | −0.89 | (−1.23 to −0.56) | 0.0082 |